Anti-CD20-Mediated B Cell Depletion Is Associated With Bone Preservation in Lymphoma Patients and Bone Mass Increase in Mice.

Frontiers in Immunology
Albert KolomanskyDrorit Neumann

Abstract

Immunotherapy with anti-CD20-specific antibodies (rituximab), has become the standard of care for B cell lymphoproliferative disorders and many autoimmune diseases. In rheumatological patients the effect of rituximab on bone mass yielded conflicting results, while in lymphoma patients it has not yet been described. Here, we used cross-sectional X-ray imaging (CT/PET-CT) to serially assess bone density in patients with follicular lymphoma receiving rituximab maintenance therapy. Remarkably, this treatment prevented the decline in bone mass observed in the control group of patients who did not receive active maintenance therapy. In accordance with these data, anti-CD20-mediated B cell depletion in normal C57BL/6J female mice led to a significant increase in bone mass, as reflected by a 7.7% increase in bone mineral density (whole femur), and a ~5% increase in cortical as well as trabecular tissue mineral density. Administration of anti-CD20 antibodies resulted in a significant decrease in osteoclastogenic signals, including RANKL, which correlated with a reduction in osteoclastogenic potential of bone marrow cells derived from B-cell-depleted animals. Taken together, our data suggest that in addition to its anti-tumor activity, a...Continue Reading

References

May 1, 1989·Immunology Today·C S Henney
Sep 1, 1994·The Journal of Clinical Investigation·T MasuzawaT Suda
Jul 15, 1993·Biochemical and Biophysical Research Communications·D BenayahuI Zan-Bar
Sep 29, 1999·Genes & Development·W C DougallJ Schuh
Mar 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·J LiW J Boyle
Aug 10, 2000·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·S TakeshitaA Kudo
Mar 29, 2001·Nature Immunology·E Montecino-RodriguezK Dorshkind
Feb 13, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·T J YunE A Clark
Aug 18, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·N ManabeM Kuro-o
Jan 5, 2002·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·T SatoK Watanabe
Dec 20, 2002·Proceedings of the National Academy of Sciences of the United States of America·Gianluca ToraldoM Neale Weitzmann
Dec 4, 2003·Experimental & Molecular Medicine·Youngnim Choi, Jeong Jae Kim
Jun 5, 2004·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Claudine Blin-WakkachGeorges F Carle
Aug 31, 2006·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Gerald J AtkinsAndrew C W Zannettino
Jul 6, 2010·Bone·Mark C HorowitzJoseph A Lorenzo
Sep 28, 2010·Lancet·David L ScottTom W J Huizinga
Sep 25, 2012·American Journal of Hematology·Arnold Freedman
Sep 18, 2013·Nature Reviews. Endocrinology·Stavros C ManolagasMaria Almeida
Jan 22, 2014·The American Journal of Gastroenterology·Nicholas K WeberDavid H Bruining
Jan 30, 2015·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Sahar Hiram-BabYankel Gabet
Aug 8, 2015·BioMed Research International·Rinaldo Florencio-SilvaPaulo Sérgio Cerri
Jan 31, 2016·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Song XuXiaochun Bai
Feb 23, 2018·Calcified Tissue International·Alanna M DubrovskyNancy E Lane
Jun 20, 2018·Frontiers in Oncology·Timothy M PierpontKristy L Richards
Aug 6, 2020·Theranostics·Naamit Deshet-UngerDrorit Neumann

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
ELISA
flow cytometry

Software Mentioned

GraphPad Prism
Kaluza software
ImageJ
Scanco

Related Concepts

Related Feeds

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.